NSE: BLUESTARCO · 6 October 2026
- Blue Star Limited shares moved upward today, gaining 4.07% to trade at Rs 1,571.50. The stock opened at Rs 1,512.30 and touched an intraday high of Rs 1,578.60 before slipping slightly to a low of Rs 1,503.00, placing it near the upper band of its daily range.
- Blue Star Limited announced that the slump sale and transfer of the MedTech business of its wholly owned subsidiary, Blue Star Engineering & Electronics Limited, to Cyrix Healthcare Private Limited was completed effectively on September 1, 2026. The division, which provided high-end medical diagnostic equipment and services, generated Rs 42.13 crores in total income during the financial year ended March 31, 2026. The total consideration for the transaction is up to Rs 40 crores, payable in tranches.
- Trading volume was 1.30 times the 20-day average daily volume.
Why is Blue Star share price rising on 6 October 2026?
Blue Star Limited shares moved upward today, gaining 4.07% to trade at Rs 1,571.50. The stock opened at Rs 1,512.30 and touched an intraday high of Rs 1,578.60 before slipping slightly to a low of Rs 1,503.00, placing it near the upper band of its daily range.
The broader market also showed positive momentum, with the Nifty rising 0.98% during the session. Blue Star's advance outpaced the broader benchmark, building upon its recent short-term strength that includes a 2.75% return over the past 5 trading days and a 7.57% gain over the past 20 trading days.
While no single corporate announcement was released today to directly trigger the price movement, the stock's recent operational backdrop includes the completion of the slump sale of its MedTech division to Cyrix Healthcare Private Limited as of September 1, 2026, for a consideration of up to Rs 40 crores. Additionally, the company is currently conducting a postal ballot through October 16, 2026, seeking shareholder approval for the appointment of Nikhilesh Panchal as an Independent Director. These corporate developments provide underlying context rather than a proven direct catalyst for today's specific price advance.
8.64 lakh shares traded by 6 October 2026 · 03:15 PM IST. This compares with a 20-day average daily volume of 6.62 lakh shares (1.30 times). The five-day average daily volume was 5.90 lakh shares. Separately, the NSE report for 5 October 2026 showed 55,648 shares delivered, representing 15.13% of that day’s traded volume. The same report recorded 25,694 trades.
Today's 4.07% rise occurred alongside elevated trading volumes (1.47x of 5-day average) in a positive broader market environment. In the absence of a same-day news trigger, the move reflects sustained technical momentum and ongoing interest following recent business reorganization updates.
Latest Company Developments
Blue Star Limited announced that the slump sale and transfer of the MedTech business of its wholly owned subsidiary, Blue Star Engineering & Electronics Limited, to Cyrix Healthcare Private Limited was completed effectively on September 1, 2026. The division, which provided high-end medical diagnostic equipment and services, generated Rs 42.13 crores in total income during the financial year ended March 31, 2026. The total consideration for the transaction is up to Rs 40 crores, payable in tranches.
Demonstrates the company's execution of strategic portfolio rationalization to focus on core operations.
The company issued a postal ballot notice to seek shareholders' approval for the appointment of Nikhilesh Panchal as an Independent Director for a five-year term commencing from August 14, 2026, to August 13, 2031. The remote e-voting period opened on September 17, 2026, and is scheduled to close on October 16, 2026, with results to be declared on or before October 18, 2026.
Facilitates corporate governance compliance and board reconstitution.
Blue Star informed exchanges that W.J. Towell & Co LLC (WJT) approached the Dubai Court of Appeal seeking the annulment of an arbitration award previously issued in favor of Blue Star by the International Chamber of Commerce. The original arbitration involved claims amounting to OMR 2.11 crore (approx. Rs 461.74 crores), which the arbitrator had dismissed in July 2026. Blue Star stated that it will contest the annulment proceedings, maintaining that WJT's grounds are baseless.
Highlights ongoing legal developments concerning international joint-venture disputes, though financial impacts remain contested.
Communication to shareholders Financial Results for the First Quarter ended on June 30, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 21.62% on 30 June 2026. This compares with 22.05% on 31 March 2026, a change of -0.43 percentage points.
The filing reported 32 MF/UTI holders.
What to Watch Next
- Outcome of the ongoing postal ballot regarding the appointment of the independent director, concluding on October 16, 2026.
- Developments regarding the Dubai Court of Appeal proceedings concerning the Oman arbitration matter.
- Upcoming un-audited standalone and consolidated financial results scheduled for board consideration on October 29, 2026.
- Cash volume, delivery percentages, and trading participation trends relative to the 20-day average volume of 1.30x.
Other Dated Coverage
- Why Blue Star Shares Are Up 3.45% Today: Price Action & Context | 5 October 2026 — 5 October 2026
- Why Blue Star Shares Fell 3.85% Today to Near 52-Week Lows | 1 October 2026 — 1 October 2026
- Why Blue Star Share Price Fell Today | Blue Star Stock Analysis | 29 September 2026 — 29 September 2026
More Blue Star news and dated analysis →
Frequently Asked Questions
What is the latest Blue Star company news?
Blue Star Limited announced that the slump sale and transfer of the MedTech business of its wholly owned subsidiary, Blue Star Engineering & Electronics Limited, to Cyrix Healthcare Private Limited was completed effectively on September 1, 2026. The division, which provided high-end medical diagnostic equipment and services, generated Rs 42.13 crores in total income during the financial year ended March 31, 2026. The total consideration for the transaction is up to Rs 40 crores, payable in tranches.
How strong was Blue Star’s trading volume?
8.64 lakh shares traded, 1.30 times the 20-day average daily volume. The price and volume data are dated 6 October 2026 · 03:15 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 June 2026. Quarterly holdings do not identify purchases made on the article date.
Article by: WittyTrades Research Desk
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.